NCT00210288View on ClinicalTrials.gov

Healthy Adult Volunteer Study for Two Doses of a Shigella Vaccine

PHASE2CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

September 30, 2006

Study Completion Date

April 30, 2007

Conditions
Shigella Infection
Interventions
BIOLOGICAL

SC599

Trial Locations (2)

75014

CIC de Vaccinologie Cochin Pasteur, Paris

SW17 0QT

Dept of Cellular and Molecular Medicine, St George's Hospital Vaccine Institute, London

Sponsors

Lead Sponsor

Institut Pasteur
All Listed Sponsors
lead

Institut Pasteur

INDUSTRY